{
    "title": "103_hr1926",
    "content": "The \"National Narcotics Leadership Act Amendments of 1993\" allows the Director to request funding for specific initiatives in line with the President's priorities for the National Drug Control Strategy. Additionally, there are amendments regarding reprogramming reports and restrictions on office personnel. The Director must report quarterly to Congress on the need for reprogramming funds over $5,000,000 for National Drug Control Program activities. Additionally, Federal officers in the Office of National Drug Control Policy appointed by the President cannot participate in Federal election campaign activities, except for making contributions to individual candidates. SEC. 4. NATIONAL DRUG CONTROL STRATEGY OUTCOME MEASURES. Section 1005(a) of the National Narcotics Leadership Act of 1988 is amended to include an evaluation of Federal drug control effectiveness in the National Drug Control Strategy, assessing reduction of drug use and prevalence among high-risk populations. The National Narcotics Leadership Act of 1988 is amended to evaluate Federal drug control effectiveness in the National Drug Control Strategy, focusing on reducing drug availability and use among high-risk populations like school dropouts, the homeless, arrestees, parolees, probationers, and juvenile delinquents. This includes assessing quantities of cocaine, heroin, and marijuana available in the US, as well as the cultivation and destruction of poppy and coca plants. The evaluation of Federal drug control effectiveness in the National Drug Control Strategy includes assessing the number of metric tons of heroin and cocaine seized, cocaine processing labs destroyed, changes in price and purity of drugs, controlled substances diverted from legitimate sources, and the effectiveness of technology programs at improving drug detection at US ports of entry. Additionally, it assesses the reduction of consequences of drug use, including the burdens placed on hospitals by drug users. The evaluation of Federal drug control effectiveness in the National Drug Control Strategy includes assessing the burdens drug users place on hospital emergency rooms in the United States, the annual national health care costs of drug use, drug-related crime and criminal activity, and the contribution of drugs to the underground economy. The evaluation includes assessing drug treatment capacity in the United States, availability of treatment for intravenous drug users and pregnant women, estimated number of drug users who could benefit from treatment, and the success of drug treatment programs. The Director will assess the quality of drug use measurement instruments and techniques for supply and demand reduction activities in the National Drug Control Strategy. The Director will assess the adequacy of national drug use measurement instruments and techniques, identify deficiencies, and propose remedies to improve treatment availability. Federal agencies are responsible for collecting drug-related information for the National Drug Control Strategy. The Director will report to the President and Congress on drug use and availability in the US, including the effectiveness of various programs under the National Drug Control Strategy. SEC. 5 amends Section 402(a)(7) of title 50, US Code to include the Director of the Office of National Drug Control Policy as a member of the National Security Council. SEC. 6 establishes the Counter-Drug Technology Assessment Center. The National Narcotics Leadership Act of 1988 is amended to support the application of technology in drug treatment through interagency agreements or grants subjected to peer review. Additionally, the Advanced Research Project Agency will provide assistance and support to the Office of National Drug Control. The National Narcotics Leadership Act of 1988 is amended to support technology in drug treatment through interagency agreements or grants. The Director of the Advanced Research Project Agency will assist the Office of National Drug Control Policy. Section 1008 is repealed and redesignated to follow section 1007. SEC. 7 amends Section 1005(a)(3) of the National Narcotics Leadership Act to allow the Director to pay for necessary expenses for consultation on the National Drug Control Strategy. SEC. 8 authorizes appropriations as needed for fiscal year 1994. SEC. 9 changes the termination date of the Office of National Drug Control Policy to September 30, 1994. The House of Representatives passed the bill on November 21, 1993. Clerk: DONNALD K. ANDERSON."
}